Apotex Leapfrogs Dr Reddy’s With First Canadian Semaglutide Launch – Citeline News & Insights

Apotex Leapfrogs Dr Reddy’s With First Canadian Semaglutide Launch  Citeline News & InsightsDr. Reddy’s launches generic semaglutide injection in Canada, first approval in a G7 market  ETPharma.comDr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in Canada  The Economic TimesApotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada  PR NewswireDr. Reddy’s Laboratories Ltd Stock 12‑Month Price Target Cut to $13.78, Implies 11% Upside  TradingView